ATXS
Price
$4.95
Change
+$0.16 (+3.34%)
Updated
Dec 5, 6:59 PM EST
100 days until earnings call
CABA
Price
$15.63
Change
-$0.43 (-2.68%)
Updated
Dec 5, 6:59 PM EST
100 days until earnings call
Ad is loading...

Analysis and predictions ATXS vs CABA

Header iconATXS vs CABA Comparison
Open Charts ATXS vs CABABanner chart's image
Astria Therapeutics
Price$4.95
Change+$0.16 (+3.34%)
Volume$401.2K
CapitalizationN/A
Cabaletta Bio
Price$15.63
Change-$0.43 (-2.68%)
Volume$372.22K
CapitalizationN/A
View a ticker or compare two or three
ATXS vs CABA Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
ATXS vs. CABA commentary
Dec 06, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATXS is a Buy and CABA is a Buy.

COMPARISON
Comparison
Dec 06, 2023
Stock price -- (ATXS: $4.95 vs. CABA: $15.63)
Brand notoriety: ATXS and CABA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATXS: 171% vs. CABA: 35%
Market capitalization -- ATXS: $170.96M vs. CABA: $801.28M
ATXS [@Biotechnology] is valued at $170.96M. CABA’s [@Biotechnology] market capitalization is $801.28M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATXS’s FA Score shows that 0 FA rating(s) are green whileCABA’s FA Score has 0 green FA rating(s).

  • ATXS’s FA Score: 0 green, 5 red.
  • CABA’s FA Score: 0 green, 5 red.
According to our system of comparison, CABA is a better buy in the long-term than ATXS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATXS’s TA Score shows that 4 TA indicator(s) are bullish while CABA’s TA Score has 6 bullish TA indicator(s).

  • ATXS’s TA Score: 4 bullish, 4 bearish.
  • CABA’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, CABA is a better buy in the short-term than ATXS.

Price Growth

ATXS (@Biotechnology) experienced а +7.84% price change this week, while CABA (@Biotechnology) price change was +14.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.01%. For the same industry, the average monthly price growth was +25.34%, and the average quarterly price growth was +25.64%.

Reported Earning Dates

ATXS is expected to report earnings on Mar 14, 2024.

CABA is expected to report earnings on Mar 14, 2024.

Industries' Descriptions

@Biotechnology (+11.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ATXS with price predictions.
OPEN
A.I.dvisor published
a Summary for CABA with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CABA($801M) has a higher market cap than ATXS($171M). CABA YTD gains are higher at: 68.973 vs. ATXS (-66.756). ATXS has higher annual earnings (EBITDA): -63.12M vs. CABA (-66.37M). ATXS has more cash in the bank: 189M vs. CABA (164M). ATXS has less debt than CABA: ATXS (488K) vs CABA (4.27M). ATXS (0) and CABA (0) have equivalent revenues.
ATXSCABAATXS / CABA
Capitalization171M801M21%
EBITDA-63.12M-66.37M95%
Gain YTD-66.75668.973-97%
P/E RatioN/AN/A-
Revenue00-
Total Cash189M164M115%
Total Debt488K4.27M11%
FUNDAMENTALS RATINGS
ATXS: Fundamental Ratings
ATXS
OUTLOOK RATING
1..100
35
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
PROFIT vs RISK RATING
1..100
57
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATXSCABA
RSI
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 2 days ago
87%
Declines
ODDS (%)
Bearish Trend 23 days ago
89%
Bearish Trend 15 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DNLRX54.60N/A
N/A
BNY Mellon Active MidCap I
JCICX60.96N/A
N/A
JPMorgan U.S. GARP Equity C
RYCMX33.51N/A
N/A
Rydex Russell 2000 1.5x Strategy C
HRLIX8.84N/A
N/A
Hartford Real Asset I
CZMVX15.14N/A
N/A
Multi-Manager Value Strategies Inst

ATXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATXS has been loosely correlated with MDGL. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ATXS jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATXS
1D Price
Change %
ATXS100%
+3.34%
MDGL - ATXS
39%
Loosely correlated
+5.91%
KALV - ATXS
35%
Loosely correlated
+0.34%
IMGN - ATXS
32%
Poorly correlated
N/A
VOR - ATXS
31%
Poorly correlated
+6.51%
RARE - ATXS
31%
Poorly correlated
+1.94%
More

CABA and

Correlation & Price change

A.I.dvisor tells us that CABA and CDTX have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CABA and CDTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CABA
1D Price
Change %
CABA100%
-2.68%
CDTX - CABA
33%
Poorly correlated
+3.43%
ORMP - CABA
32%
Poorly correlated
-0.93%
ICVX - CABA
31%
Poorly correlated
-6.74%
PSTX - CABA
30%
Poorly correlated
+4.73%
IOVA - CABA
29%
Poorly correlated
-5.50%
More